Evidence map›Paper›PMID 40102455›Full record

ArticleScientific reports2025

Author Correction: The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study.

Neslihan Özyurt, Ali Alkan, Burcu Gülbağcı, Mustafa Seyyar, Esra Aşık, Mustafa Şahbazlar, Mehmet Türker, Oğuzcan Kınıkoğlu, Tahir Yerlikaya, Gülhan Dinç and 32 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

42 authors.

Neslihan ÖzyurtDepartment of Medical Oncology, Ordu University School of Medicine, Ordu, Turkey.
Ali AlkanDepartment of Medical Oncology, Muğla Sıtkı Koçman University School of Medicine, Muğla, Turkey. alkanali@yahoo.com.ORCID http://orcid.org/0000-0002-8253-5046
Burcu GülbağcıDepartment of Medical Oncology, Sakarya University School of Medicine, Sakarya, Turkey.
Mustafa SeyyarDepartment of Medical Oncology, Kocaeli University School of Medicine, İzmit, Turkey.
Esra AşıkDepartment of Medical Oncology, Karadeniz Technical University School of Medicine, Trabzon, Turkey.
Mustafa ŞahbazlarDepartment of Medical Oncology, Celal Bayar University School of Medicine, Manisa, Turkey.
Mehmet TürkerDepartment of Medical Oncology, Çukurova University School of Medicine, Adana, Turkey.
Oğuzcan KınıkoğluDepartment of Medical Oncology, Kartal Training and Research Hospital, İstanbul, Turkey.
Tahir YerlikayaDepartment of Medical Oncology, Antalya Training and Research Hospital, Antalya, Turkey.
Gülhan DinçDepartment of Medical Oncology, Okmeydanı Training and Research Hospital, İstanbul, Turkey.
Ali AytaçDepartment of Medical Oncology, Aydın Adnan Menderes University School of Medicine, Aydın, Turkey.
Ziya KalkanDepartment of Medical Oncology, Dicle University School of Medicine, Diyarbakır, Turkey.
Senar EbinçDiyarbakır Training and Research Hospital, Department of Medical Oncology, Diyarbakır, Turkey.
İlkay GültürkDepartment of Medical Oncology, Bakırköy Sadi Konuk Training and Research Hospital, İstanbul, Turkey.
Merve KeskinkılıçDepartment of Medical Oncology, Dokuz Eylül University School of Medicine, İzmir, Turkey.
Zehra Sucuoğlu İşleyenDepartment of Medical Oncology, Bezm-i Alem Vakıf University School of Medicine, İstanbul, Turkey.
Dilek ÇağlayanDepartment of Medical Oncology, Necmettin Erbakan University School of Medicine, Konya, Turkey.
Alper TürkelDepartment of Medical Oncology, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey.
Esra AydınDepartment of Medical Oncology, Recep Tayyip Erdoğan University School of Medicine, Rize, Turkey.
Teoman ŞakalarDepartment of Medical Oncology, Kahramanmaraş Necip Fazıl City Hospital, Kahramanmaraş, Turkey.
Serhat SekmekAnkara Bilkent City Hospital, Department of Medical Oncology, Ankara, Turkey.
Nilgün YıldırımDepartment of Medical Oncology, Fırat University School of Medicine, Elazığ, Turkey.
Sinem KoçakDepartment of Medical Oncology, Koç University School of Medicine, İstanbul, Turkey.
Kerem OkuturDepartment of Medical Oncology, İstanbul Arel University School of Medicine, İstanbul, Turkey.
Ahmet ÖzverenDepartment of Medical Oncology, Acıbadem Kent Hospital, İzmir, Turkey.
Bengü DursunDepartment of Medical Oncology, Ankara University School of Medicine, Ankara, Turkey.
Sait KitaplıDepartment of Medical Oncology, Muğla Sıtkı Koçman University School of Medicine, Muğla, Turkey.
Orhan Önder ErenDepartment of Medical Oncology, Selçuk University School of Medicine, Konya, Turkey.
İsmail BeypınarDepartment of Medical Oncology, Alanya Alaittin Keykubat University School of Medicine, Antalya, Turkey.
İlhan HacıbekiroğluDepartment of Medical Oncology, Sakarya University School of Medicine, Sakarya, Turkey.
Devrim ÇabukDepartment of Medical Oncology, Kocaeli University School of Medicine, İzmit, Turkey.
Elanur KaramanDepartment of Medical Oncology, Karadeniz Technical University School of Medicine, Trabzon, Turkey.
Ömer AcarDepartment of Medical Oncology, Celal Bayar University School of Medicine, Manisa, Turkey.
Semra PaydaşDepartment of Medical Oncology, Çukurova University School of Medicine, Adana, Turkey.
Melek Karakurt EryılmazDepartment of Medical Oncology, Necmettin Erbakan University School of Medicine, Konya, Turkey.
Bilgin DemirDepartment of Medical Oncology, Aydın Adnan Menderes University School of Medicine, Aydın, Turkey.
Zeynep OruçDepartment of Medical Oncology, Dicle University School of Medicine, Diyarbakır, Turkey.
Mesut YılmazDepartment of Medical Oncology, Bakırköy Sadi Konuk Training and Research Hospital, İstanbul, Turkey.
Fatih Selçuk BiricikDepartment of Medical Oncology, Koç University School of Medicine, İstanbul, Turkey.
Derya Kıvrak SalimDepartment of Medical Oncology, Antalya Training and Research Hospital, Antalya, Turkey.
Özgür TanrıverdiDepartment of Medical Oncology, Muğla Sıtkı Koçman University School of Medicine, Muğla, Turkey.
Mutlu DoğanDepartment of Medical Oncology, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40102455
PMCPMC11920419

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.